Inactivated vaccine against viral hemorrhagic septicemia (VHS) emulsified with squalene and aluminum hydroxide adjuvant provides long term protection in olive flounder (Paralichthys olivaceus)

Vaccine

Volumn 31, Issue 41, 2013, Pages 4603-4610

  Vinay, Tharabenahalli Nagaraju ^a   Kim, Ye Ji ^a   Jung, Myung Hwa ^a   Kim, Wi Sik ^a   Kim, Do Hyung ^a   Jung, Sung Ju ^a  

^a Chonnam National University   (South Korea)

Author keywords

Adjuvant; Aluminum hydroxide; Olive flounder; Squalene emulsion; VHSV vaccine

Indexed keywords

ALUMINUM HYDROXIDE; INACTIVATED VACCINE; SQUALENE;

ANTIBODY TITER; ARTICLE; EMULSION; INFLAMMATION; LOW TEMPERATURE; NONHUMAN; PARALICHTHYS OLIVACEUS; PRIORITY JOURNAL; VACCINATION; VIRAL HEMORRHAGIC SEPTICEMIA; VIRAL HEMORRHAGIC SEPTICEMIA VIRUS;

ADJUVANT; ALUMINUM HYDROXIDE; OLIVE FLOUNDER; SQUALENE EMULSION; VHSV VACCINE;

ADJUVANTS, IMMUNOLOGIC; ALUMINUM HYDROXIDE; ANIMALS; ANTIBODIES, VIRAL; AQUACULTURE; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FISH DISEASES; FLOUNDER; HEMORRHAGIC SEPTICEMIA, VIRAL; KOREA; SQUALENE; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VACCINES, INACTIVATED; VIRAL VACCINES;

EID: 84883600746     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.07.036     Document Type: Article

References (45)

1. Xu G., Sheng X., Xing J., Zhan W. Effect of temperature on immune response of Japanese flounder (Paralichthys olivaceus) to inactivated lymphocystis disease virus (LCDV). Fish and Shellfish Immunology 2011, 30:525-531.
2. Seikai T. Flounder culture and its challenges in Asia. Reviews in Fisheries Sciences 2002, 10:421-432.
3. Oh S.P., Kim D.H., Lee J.J., Lee C.H. Bacterial diseases in olive flounder farms on Cheju Island, Korea. Journal of Fish Pathology 1998, 11:23-27.
4. Jung S.J., Kitamura S.I., Song J.Y., Joung I.Y., Oh M.J. Complete small subunit rRNA gene sequence of the scuticociliate Miamiensis avidus pathogenic to olive flounder Paralichthys olivaceus. Diseases of Aquatic Organisms 2005, 64:159-162.
5. Oh M.J., Kim W.S., Kitamura S.I., Lee H.K., Son B.W., Jung T.S., et al. Change of pathogenicity in olive flounder Paralichthys olivaceus by co-infection of Vibrio harveyi, Edwardsiella tarda and marine birnavirus. Aquaculture 2006, 257:156-160.
6. Park S.I. Disease control in Korean aquaculture. Fish Pathology 2009, 44:19-23.
7. Kim W.S., Kim S.R., Kim D., Kim J.O., Park M.A., Kitamura S.I., et al. An outbreak of VHSV (viral hemorrhagic septicemia virus) infection in farmed olive flounder Paralichthys olivaceus in Korea. Aquaculture 2009, 296:165-168.
8. Nishizawa T., Takami I., Yang M., Oh M.J. Live vaccine of viral hemorrhagic septicaemia virus (VHSV) for Japanese flounder at fish rearing temperature of 21°C instead of Poly (I:C) administration. Vaccine 2011, 29:8397-8404.
9. Avunje S., Kim W.S., Park C.S., Oh M.J., Jung S.J. Toll-like receptors and interferon associated immune factors in viral haemorrhagic septicaemia virus-infected olive flounder (Paralichthys olivaceus). Fish and Shellfish Immunology 2011, 31:407-414.
10. Isshiki T., Nishizawa T., Kobayashi T., Nagano T., Miyazaki T. An outbreak of VHSV (viral hemorrhagic septicemia virus) infection in farmed Japanese flounder Paralichthys olivaceus in Japan. Diseases of Aquatic Organisms 2001, 47:87-99.
11. Secombes C. Will advances in fish immunology change vaccination strategies. Fish and Shellfish Immunology 2008, 25:409-416.
12. Evensen Ø. Development in fish vaccinology with focus on delivery methodologies, adjuvants and formulations. The use of veterinary drugs and vaccines in Mediterranean aquaculture. Options Méditerranénnes 2009, 86:177-186.
13. Ragnar T., Powell D.B. Effects of disease risk, vaccine efficacy, and market price on the economics of fish vaccination. Aquaculture 2006, 256:42-49.
14. Casado G.E., Estepa A., Coll J.M. A comparative review on European-farmed finfish RNA viruses and their vaccines. Vaccine 2011, 29:2657-2671.
15. Thim H.L., Iliev D.B., Christie K.E., Villoing S., McLoughlin M.F., Strandskog G., et al. Immunoprotective activity of a salmonid alphavirus vaccine: comparision of the immune responses induced by inactivated whole virus antigen formulations based on CpG class B oligonucleotides and poly I:C alone or combined with an oil adjuvant. Vaccine 2012, 30:4828-4834.
16. Adelmann M., Kollner B., Bergmann S.M., Fisher U., Lange B., Weitschies W., et al. Development of an oral vaccine for immunization of rainbow trout (Oncorhynchus mykiss) against viral haemorrhagic septicaemia. Vaccine 2008, 26:837-844.
17. Ahne W. Serological techniques currently used in fish virology. Developments in Biological Standardization 1981, 49:3-27.
18. Hill B.J., Williams R.F., Finlay J. Preparation of antisera against fish virus disease agents. Developments in Biological Standardization 1981, 49:209-218.
19. Kinkelin P.D., Bearezotti M., Castric J., Nougayrede P., Xhonneux F.L., Thiry M. Eighteen years of vaccination against viral haemorrhagic septicaemia in France. Veterinary Research 1995, 26:379-387.
20. Biering E., Villoing S., Sommerset I., Christie K.E. Update on viral vaccines for fish. Developmental Biology 2005, 121:97-113.
21. Midtlyng P.J., Lillehaug A. Growth of Atlantic salmon Salmo salar after intraperitoneal administration of vaccines containing adjuvants. Diseases of Aquatic Organisms 1998, 32:91-97.
22. Midtlyng P.J., Reitan L.J., Lillehaug A., Ramstad A. Protection, immune responses and side effects in Atlantic salmon (Salmo salar L.) vaccinated against furunculosis by different procedures. Fish and Shellfish Immunology 1996, 6:599-613.
23. Poppe T.T., Breck O. Pathology of Atlantic salmon Salmo salar intra-peritoneally immunized with oil-adjuvanted vaccine. A case report. Diseases of Aquatic Organisms 1997, 29:219-226.
24. Bowden T.J., Adamson K., MacLachan P., Pert C.C., Bricknell I.R. Long-term study of antibody response and injection-site effects of oil adjuvants in Atlantic halibut (Hippoglossus hippoglossus L.). Fish and Shellfish Immunology 2003, 14:363-369.
25. Mutoloki S., Alexandersen S., Evensen Ø. Sequential study of antigen persistence and concomitant inflammatory reactions relative to side-effects and growth of Atlantic salmon (Salmo salar L.) following intraperitoneal injection with oil-adjuvanted vaccines. Fish and Shellfish Immunology 2004, 16:633-644.
26. Evensen Ø., Brudeseth B., Mutoloki The vaccine formulation and its role in inflammatory processes in fish - effects and adverse effects. Developmental Biology 2005, 121:117-125.
27. Drangsholt T.M.K., Gjerde B., Ødegård J., Fridell F., Bentsen H.B. Quantitative genetics of vaccine-induced side effects in farmed Atlantic salmon (Salmo salar). Aquaculture 2011, 318:316-324.
28. Schultze V., Agosto V.D., Wack A., Novicki D., Zorn J., Hennig R. Safety of MF59™ adjuvant. Vaccine 2008, 26:3209-3222.
29. Rahman M.H., Ototake M., Iida T., Yokomizo Y., Nakanishi T. Efficacy of oil-adjuvanted vaccine for coldwater disease in Ayu Plecoglossus altivelis. Fish Pathology 2000, 35:199-203.
30. Miller T.A., Rapp J., Wastlhuber U., Hoffmann R.W., Enzmann P.J. Rapid and sensitive reverse transcriptase-polymerase chain reaction based detection and differential diagnosis of fish pathogenic rhabdoviruses in organ samples and cultured cells. Diseases of Aquatic Organisms 1998, 34:13-20.
31. Kim W.S., Mochizuki M., Nishizawa T., Yoshimizu M. Detection of specific antibodies against infectious hematopoietic necrosis virus from rainbow trout sera by ELISA using two novirhabdovirusus. Fish Pathology 2008, 43:112-116.
32. Nishida H., Enokida T., Hiramatsu N., Hara A., Yoshimizu M. Purification of immunoglobulin M (IgM) in serum of Japanese flounder (Paralichthys olivacious). Bulletin of the Faculty of Fisheries Hokkaido University 1998, 49:157-164.
33. Amend D.F. Potency testing of fish vaccines. Developments in Biological Standardization 1981, vol. 49:447-454. Fish biologics. Serodiagnostics and vaccines, Basel.
34. Cox J.C., Coulter A.R. Adjuvants-a classification and review of their modes of action. Vaccine 1997, 15:248-256.
35. O'Hagan D.T., Ott G.S., Gregorio E.D., Seubert A. The mechanism of action of MF59 - an innately attractive adjuvant formulation. Vaccine 2012, 30:4341-4348.
36. Fry F.E.J. Responses of vertebrate poikilotherms to temperature. Thermobiology. 1967, 375-409. Academic Press, London, New York. A.H. Rose (Ed.).
37. Johnston I.A., Dunn J. Temperature acclimation and metabolism in ectotherms with particular reference to teleost fish. Symposia of the Society for Experimental Biology 1987, 41:67-93.
38. Ellis A.E. Optimising factors for fish vaccination. Fish vaccination 1988, 32-46. Academic Press, London. 1st ed. A.E. Ellis (Ed.).
39. Manning M.J., Nakanishi T. The specific immune system: cellular defense. 5. Effect of temperature. The fish immune system. Organism, pathogen and environment 1996, 183-185. Academic Press. G. Iwama, T. Nakanishi (Eds.).
40. Weiss E., Avtalion I.I. Regulatory effect of temperature and antigen upon immunity in ectothermic vertebrates. II. Primary enhancement of anti-hapten antibody response at high and low temperatures. Developmental and Comparative Immunology 1977, 1:93-94.
41. Avtalion R.R. Environmental control of immune response in fish. Critical Reviews in Environmental Control 1981, 11:163-188.
42. Korea-US-Aquaculture 2013, available at: http://www.lib.noaa.gov/retiredsites/korea/main species/flounder.htm.
43. Lorenzen N., LaPatra S.E. Immunity to rhabdoviruses in rainbow trout: the antibody response. Fish and Shellfish Immunology 1999, 9:345-360.
44. Fox C.B. Squalene emulsions for parenteral vaccine and drug delivery. Molecules 2009, 14:3286-3312.
45. Vinay T.N., Park C.S., Kim H.Y., Jung S.J. Toxicity and dose determination of quillaja saponin, aluminum hydroxide and squalene in olive flounder (Paralichthys olivaceus). Veterinary Immunology and Immunopathology 2013, doi:10.1016/j.vetimm.2013.03.007.